Clinical Trial Update: A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effects of paliperidone extended-release versus risperidone immediate-release on cognitive function in clinically stable schizoph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone Extended Release (paliperidone extended-release)
• Risperidone Immediate-release (risperidone)

Snippet

Sponsor: Johnson & Johnson Taiwan Ltd | Conditions: Schizophrenia | Phase 4 | Status: TERMINATED